©The Author(s) 2017.
World J Gastroenterol. Jun 14, 2017; 23(22): 3978-3998
Published online Jun 14, 2017. doi: 10.3748/wjg.v23.i22.3978
Published online Jun 14, 2017. doi: 10.3748/wjg.v23.i22.3978
Table 4 Summary of global gene expression studies in gallbladder cancer
| Biological sample used | Platform/studies key findings | Ref. |
| 17 gallbladder tissue specimens (6 advanced GBC , 6 early GBC cancers and 5 normal control | Oligonucleotide Microarray platform | [97] |
| Unregulated genes: 2270 | ||
| Downregulated genes: 2412 | ||
| 5-Normal biliary epithelial scrapings, 11- surgically resected biliary carcinomas, 9-biliary cancer cell lines | Oligonucleotide Microarray platform | [98] |
| Unregulated genes : 282 genes | ||
| Downregulated genes: 513 | ||
| 37 biliary tract carcinomas | cDNA array platform | [99] |
| (15 bile duct, 11 gallbladder, 11 of ampulla of Vater) | 118 genes were identified with a prognostic value | |
| 12 advanced gallbladder carcinoma tissue 3 samples of normal control gallbladder epithelium | Oligonucleotide Array platform | [100] |
| Upregulated: (TOPO II-alpha, cyclin B2, CDC28, ubiquitin-conjugating enzyme E2C), and one metabolism-related: (gamma-glutamyl hydrolase) | [101] | |
| 34 biliary tract cancers including | Oligonucleotide Array platform | |
| 13 intrahepatic (IHC), 12extrahepatic (EHC), 9 (GBC) | 1281 genes with deregulated expression pattern |
- Citation: Sharma A, Sharma KL, Gupta A, Yadav A, Kumar A. Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update. World J Gastroenterol 2017; 23(22): 3978-3998
- URL: https://www.wjgnet.com/1007-9327/full/v23/i22/3978.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i22.3978